Global Maternal Pertussis Vaccine for Newborn Protection Market Growth 2026-2032
The global Maternal Pertussis Vaccine for Newborn Protection market size is predicted to grow from US$ 5834 million in 2025 to US$ 7454 million in 2032; it is expected to grow at a CAGR of 3.6% from 2026 to 2032.
In 2024, global Maternal Pertussis Vaccine for Newborn Protection production reached approximately 350 million doses, with an average global market price of around US$ 16 per square meter. Maternal Pertussis Vaccine for Newborn Protection is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective. In this report, we cover all the pertussis-containing vaccines. Gross margin for the Maternal Pertussis Vaccine for Newborn Protection in general shows that manufacturers often achieve roughly 50–70% gross margins, depending on the producer, country, and contract.
The global Maternal Pertussis Vaccine for Newborn Protection market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The Maternal Pertussis Vaccine for Newborn Protection industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for Maternal Pertussis Vaccine for Newborn Protections is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.
LP Information, Inc. (LPI) ' newest research report, the “Maternal Pertussis Vaccine for Newborn Protection Industry Forecast” looks at past sales and reviews total world Maternal Pertussis Vaccine for Newborn Protection sales in 2025, providing a comprehensive analysis by region and market sector of projected Maternal Pertussis Vaccine for Newborn Protection sales for 2026 through 2032. With Maternal Pertussis Vaccine for Newborn Protection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Maternal Pertussis Vaccine for Newborn Protection industry.
This Insight Report provides a comprehensive analysis of the global Maternal Pertussis Vaccine for Newborn Protection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Maternal Pertussis Vaccine for Newborn Protection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Maternal Pertussis Vaccine for Newborn Protection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Maternal Pertussis Vaccine for Newborn Protection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Maternal Pertussis Vaccine for Newborn Protection.
This report presents a comprehensive overview, market shares, and growth opportunities of Maternal Pertussis Vaccine for Newborn Protection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Maternal Pertussis Vaccine for Newborn Protection market?
What factors are driving Maternal Pertussis Vaccine for Newborn Protection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Maternal Pertussis Vaccine for Newborn Protection market opportunities vary by end market size?
How does Maternal Pertussis Vaccine for Newborn Protection break out by Type, by Application?
In 2024, global Maternal Pertussis Vaccine for Newborn Protection production reached approximately 350 million doses, with an average global market price of around US$ 16 per square meter. Maternal Pertussis Vaccine for Newborn Protection is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective. In this report, we cover all the pertussis-containing vaccines. Gross margin for the Maternal Pertussis Vaccine for Newborn Protection in general shows that manufacturers often achieve roughly 50–70% gross margins, depending on the producer, country, and contract.
The global Maternal Pertussis Vaccine for Newborn Protection market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The Maternal Pertussis Vaccine for Newborn Protection industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for Maternal Pertussis Vaccine for Newborn Protections is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.
LP Information, Inc. (LPI) ' newest research report, the “Maternal Pertussis Vaccine for Newborn Protection Industry Forecast” looks at past sales and reviews total world Maternal Pertussis Vaccine for Newborn Protection sales in 2025, providing a comprehensive analysis by region and market sector of projected Maternal Pertussis Vaccine for Newborn Protection sales for 2026 through 2032. With Maternal Pertussis Vaccine for Newborn Protection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Maternal Pertussis Vaccine for Newborn Protection industry.
This Insight Report provides a comprehensive analysis of the global Maternal Pertussis Vaccine for Newborn Protection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Maternal Pertussis Vaccine for Newborn Protection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Maternal Pertussis Vaccine for Newborn Protection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Maternal Pertussis Vaccine for Newborn Protection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Maternal Pertussis Vaccine for Newborn Protection.
This report presents a comprehensive overview, market shares, and growth opportunities of Maternal Pertussis Vaccine for Newborn Protection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- DTaP
- Tdap
- DTwP
- Acellular Vaccines
- Whole-cell Vaccines
- Below 12 Months
- Above 12 Months
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- KM Biologics
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Chengdu Institute of Biological Products
- Minhai Biotechnology
What is the 10-year outlook for the global Maternal Pertussis Vaccine for Newborn Protection market?
What factors are driving Maternal Pertussis Vaccine for Newborn Protection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Maternal Pertussis Vaccine for Newborn Protection market opportunities vary by end market size?
How does Maternal Pertussis Vaccine for Newborn Protection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Maternal Pertussis Vaccine for Newborn Protection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Maternal Pertussis Vaccine for Newborn Protection by Country/Region, 2021, 2025 & 2032
2.2 Maternal Pertussis Vaccine for Newborn Protection Segment by Type
2.2.1 Acellular Pertussis Vaccine
2.2.2 Whole-cell Pertussis Vaccine
2.2.3 Maternal Pertussis Vaccine for Newborn Protection Sales by Type
2.2.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Type (2021-2026)
2.3 Maternal Pertussis Vaccine for Newborn Protection Segment by Application
2.3.1 Hospital
2.3.2 Centers for Disease Control and Prevention
2.3.3 Others
2.3.4 Maternal Pertussis Vaccine for Newborn Protection Sales by Application
2.3.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Maternal Pertussis Vaccine for Newborn Protection Breakdown Data by Company
3.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Annual Sales by Company (2021-2026)
3.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Company (2021-2026)
3.2 Global Maternal Pertussis Vaccine for Newborn Protection Annual Revenue by Company (2021-2026)
3.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Company (2021-2026)
3.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Company (2021-2026)
3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Company
3.4 Key Manufacturers Maternal Pertussis Vaccine for Newborn Protection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Maternal Pertussis Vaccine for Newborn Protection Product Location Distribution
3.4.2 Players Maternal Pertussis Vaccine for Newborn Protection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION BY GEOGRAPHIC REGION
4.1 World Historic Maternal Pertussis Vaccine for Newborn Protection Market Size by Geographic Region (2021-2026)
4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Maternal Pertussis Vaccine for Newborn Protection Market Size by Country/Region (2021-2026)
4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Maternal Pertussis Vaccine for Newborn Protection Sales Growth
4.4 APAC Maternal Pertussis Vaccine for Newborn Protection Sales Growth
4.5 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Growth
4.6 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Growth
5 AMERICAS
5.1 Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Country
5.1.1 Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
5.1.2 Americas Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026)
5.2 Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026)
5.3 Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Region
6.1.1 APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021-2026)
6.1.2 APAC Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2021-2026)
6.2 APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026)
6.3 APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Maternal Pertussis Vaccine for Newborn Protection by Country
7.1.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
7.1.2 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026)
7.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026)
7.3 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection by Country
8.1.1 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026)
8.2 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026)
8.3 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Maternal Pertussis Vaccine for Newborn Protection
10.3 Manufacturing Process Analysis of Maternal Pertussis Vaccine for Newborn Protection
10.4 Industry Chain Structure of Maternal Pertussis Vaccine for Newborn Protection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
11.3 Maternal Pertussis Vaccine for Newborn Protection Customer
12 WORLD FORECAST REVIEW FOR MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION BY GEOGRAPHIC REGION
12.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Region
12.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Forecast by Region (2027-2032)
12.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Maternal Pertussis Vaccine for Newborn Protection Forecast by Type (2027-2032)
12.7 Global Maternal Pertussis Vaccine for Newborn Protection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.2.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Intravacc
13.3.1 Intravacc Company Information
13.3.2 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.3.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Intravacc Main Business Overview
13.3.5 Intravacc Latest Developments
13.4 Zhifei Biological
13.4.1 Zhifei Biological Company Information
13.4.2 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.4.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zhifei Biological Main Business Overview
13.4.5 Zhifei Biological Latest Developments
13.5 Walvax
13.5.1 Walvax Company Information
13.5.2 Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.5.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Walvax Main Business Overview
13.5.5 Walvax Latest Developments
13.6 Minhai Biological
13.6.1 Minhai Biological Company Information
13.6.2 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.6.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Minhai Biological Main Business Overview
13.6.5 Minhai Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Maternal Pertussis Vaccine for Newborn Protection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Maternal Pertussis Vaccine for Newborn Protection by Country/Region, 2021, 2025 & 2032
2.2 Maternal Pertussis Vaccine for Newborn Protection Segment by Type
2.2.1 Acellular Pertussis Vaccine
2.2.2 Whole-cell Pertussis Vaccine
2.2.3 Maternal Pertussis Vaccine for Newborn Protection Sales by Type
2.2.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Type (2021-2026)
2.3 Maternal Pertussis Vaccine for Newborn Protection Segment by Application
2.3.1 Hospital
2.3.2 Centers for Disease Control and Prevention
2.3.3 Others
2.3.4 Maternal Pertussis Vaccine for Newborn Protection Sales by Application
2.3.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Maternal Pertussis Vaccine for Newborn Protection Breakdown Data by Company
3.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Annual Sales by Company (2021-2026)
3.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Company (2021-2026)
3.2 Global Maternal Pertussis Vaccine for Newborn Protection Annual Revenue by Company (2021-2026)
3.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Company (2021-2026)
3.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Company (2021-2026)
3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Company
3.4 Key Manufacturers Maternal Pertussis Vaccine for Newborn Protection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Maternal Pertussis Vaccine for Newborn Protection Product Location Distribution
3.4.2 Players Maternal Pertussis Vaccine for Newborn Protection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION BY GEOGRAPHIC REGION
4.1 World Historic Maternal Pertussis Vaccine for Newborn Protection Market Size by Geographic Region (2021-2026)
4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Maternal Pertussis Vaccine for Newborn Protection Market Size by Country/Region (2021-2026)
4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Maternal Pertussis Vaccine for Newborn Protection Sales Growth
4.4 APAC Maternal Pertussis Vaccine for Newborn Protection Sales Growth
4.5 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Growth
4.6 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Growth
5 AMERICAS
5.1 Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Country
5.1.1 Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
5.1.2 Americas Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026)
5.2 Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026)
5.3 Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Region
6.1.1 APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021-2026)
6.1.2 APAC Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2021-2026)
6.2 APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026)
6.3 APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Maternal Pertussis Vaccine for Newborn Protection by Country
7.1.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
7.1.2 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026)
7.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026)
7.3 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection by Country
8.1.1 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026)
8.2 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026)
8.3 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Maternal Pertussis Vaccine for Newborn Protection
10.3 Manufacturing Process Analysis of Maternal Pertussis Vaccine for Newborn Protection
10.4 Industry Chain Structure of Maternal Pertussis Vaccine for Newborn Protection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
11.3 Maternal Pertussis Vaccine for Newborn Protection Customer
12 WORLD FORECAST REVIEW FOR MATERNAL PERTUSSIS VACCINE FOR NEWBORN PROTECTION BY GEOGRAPHIC REGION
12.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Region
12.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Forecast by Region (2027-2032)
12.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Maternal Pertussis Vaccine for Newborn Protection Forecast by Type (2027-2032)
12.7 Global Maternal Pertussis Vaccine for Newborn Protection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.2.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Intravacc
13.3.1 Intravacc Company Information
13.3.2 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.3.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Intravacc Main Business Overview
13.3.5 Intravacc Latest Developments
13.4 Zhifei Biological
13.4.1 Zhifei Biological Company Information
13.4.2 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.4.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zhifei Biological Main Business Overview
13.4.5 Zhifei Biological Latest Developments
13.5 Walvax
13.5.1 Walvax Company Information
13.5.2 Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.5.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Walvax Main Business Overview
13.5.5 Walvax Latest Developments
13.6 Minhai Biological
13.6.1 Minhai Biological Company Information
13.6.2 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
13.6.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Minhai Biological Main Business Overview
13.6.5 Minhai Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Maternal Pertussis Vaccine for Newborn Protection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Maternal Pertussis Vaccine for Newborn Protection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Acellular Pertussis Vaccine
Table 4. Major Players of Whole-cell Pertussis Vaccine
Table 5. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021-2026)
Table 9. Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Maternal Pertussis Vaccine for Newborn Protection Sale by Application (2021-2026) & (Dose)
Table 11. Global Maternal Pertussis Vaccine for Newborn Protection Sale Market Share by Application (2021-2026)
Table 12. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021-2026)
Table 14. Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Company (2021-2026) & (Dose)
Table 16. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Company (2021-2026)
Table 17. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Company (2021-2026)
Table 19. Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Maternal Pertussis Vaccine for Newborn Protection Producing Area Distribution and Sales Area
Table 21. Players Maternal Pertussis Vaccine for Newborn Protection Products Offered
Table 22. Maternal Pertussis Vaccine for Newborn Protection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Geographic Region (2021-2026) & (Dose)
Table 26. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Country/Region (2021-2026) & (Dose)
Table 30. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Dose)
Table 34. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021-2026)
Table 35. Americas Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 37. Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Dose)
Table 38. APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021-2026) & (Dose)
Table 39. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2021-2026)
Table 40. APAC Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 42. APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Dose)
Table 43. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Dose)
Table 44. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 46. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Dose)
Table 47. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Dose)
Table 48. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 50. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Dose)
Table 51. Key Market Drivers & Growth Opportunities of Maternal Pertussis Vaccine for Newborn Protection
Table 52. Key Market Challenges & Risks of Maternal Pertussis Vaccine for Newborn Protection
Table 53. Key Industry Trends of Maternal Pertussis Vaccine for Newborn Protection
Table 54. Maternal Pertussis Vaccine for Newborn Protection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Maternal Pertussis Vaccine for Newborn Protection Distributors List
Table 57. Maternal Pertussis Vaccine for Newborn Protection Customer List
Table 58. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Region (2027-2032) & (Dose)
Table 59. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Dose)
Table 61. Americas Maternal Pertussis Vaccine for Newborn Protection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Region (2027-2032) & (Dose)
Table 63. APAC Maternal Pertussis Vaccine for Newborn Protection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Dose)
Table 65. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Dose)
Table 67. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Type (2027-2032) & (Dose)
Table 69. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Application (2027-2032) & (Dose)
Table 71. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. GlaxoSmithKline Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 73. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 74. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Latest Developments
Table 77. Sanofi Pasteur Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 79. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. Sanofi Pasteur Main Business
Table 81. Sanofi Pasteur Latest Developments
Table 82. Intravacc Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 83. Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 84. Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Intravacc Main Business
Table 86. Intravacc Latest Developments
Table 87. Zhifei Biological Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 88. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 89. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Zhifei Biological Main Business
Table 91. Zhifei Biological Latest Developments
Table 92. Walvax Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 93. Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 94. Walvax Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Walvax Main Business
Table 96. Walvax Latest Developments
Table 97. Minhai Biological Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 98. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 99. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Minhai Biological Main Business
Table 101. Minhai Biological Latest Developments
Table 1. Maternal Pertussis Vaccine for Newborn Protection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Maternal Pertussis Vaccine for Newborn Protection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Acellular Pertussis Vaccine
Table 4. Major Players of Whole-cell Pertussis Vaccine
Table 5. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021-2026)
Table 9. Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Maternal Pertussis Vaccine for Newborn Protection Sale by Application (2021-2026) & (Dose)
Table 11. Global Maternal Pertussis Vaccine for Newborn Protection Sale Market Share by Application (2021-2026)
Table 12. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021-2026)
Table 14. Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Company (2021-2026) & (Dose)
Table 16. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Company (2021-2026)
Table 17. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Company (2021-2026)
Table 19. Global Maternal Pertussis Vaccine for Newborn Protection Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Maternal Pertussis Vaccine for Newborn Protection Producing Area Distribution and Sales Area
Table 21. Players Maternal Pertussis Vaccine for Newborn Protection Products Offered
Table 22. Maternal Pertussis Vaccine for Newborn Protection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Geographic Region (2021-2026) & (Dose)
Table 26. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Country/Region (2021-2026) & (Dose)
Table 30. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Dose)
Table 34. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021-2026)
Table 35. Americas Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 37. Americas Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Dose)
Table 38. APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021-2026) & (Dose)
Table 39. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2021-2026)
Table 40. APAC Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 42. APAC Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Dose)
Table 43. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Dose)
Table 44. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 46. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Dose)
Table 47. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Dose)
Table 48. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Dose)
Table 50. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Dose)
Table 51. Key Market Drivers & Growth Opportunities of Maternal Pertussis Vaccine for Newborn Protection
Table 52. Key Market Challenges & Risks of Maternal Pertussis Vaccine for Newborn Protection
Table 53. Key Industry Trends of Maternal Pertussis Vaccine for Newborn Protection
Table 54. Maternal Pertussis Vaccine for Newborn Protection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Maternal Pertussis Vaccine for Newborn Protection Distributors List
Table 57. Maternal Pertussis Vaccine for Newborn Protection Customer List
Table 58. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Region (2027-2032) & (Dose)
Table 59. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Dose)
Table 61. Americas Maternal Pertussis Vaccine for Newborn Protection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Region (2027-2032) & (Dose)
Table 63. APAC Maternal Pertussis Vaccine for Newborn Protection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Dose)
Table 65. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2027-2032) & (Dose)
Table 67. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Type (2027-2032) & (Dose)
Table 69. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Application (2027-2032) & (Dose)
Table 71. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. GlaxoSmithKline Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 73. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 74. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Latest Developments
Table 77. Sanofi Pasteur Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 79. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. Sanofi Pasteur Main Business
Table 81. Sanofi Pasteur Latest Developments
Table 82. Intravacc Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 83. Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 84. Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Intravacc Main Business
Table 86. Intravacc Latest Developments
Table 87. Zhifei Biological Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 88. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 89. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Zhifei Biological Main Business
Table 91. Zhifei Biological Latest Developments
Table 92. Walvax Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 93. Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 94. Walvax Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Walvax Main Business
Table 96. Walvax Latest Developments
Table 97. Minhai Biological Basic Information, Maternal Pertussis Vaccine for Newborn Protection Manufacturing Base, Sales Area and Its Competitors
Table 98. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolios and Specifications
Table 99. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Minhai Biological Main Business
Table 101. Minhai Biological Latest Developments
LIST OF FIGURES
Figure 1. Picture of Maternal Pertussis Vaccine for Newborn Protection
Figure 2. Maternal Pertussis Vaccine for Newborn Protection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate 2021-2032 (Dose)
Figure 7. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Maternal Pertussis Vaccine for Newborn Protection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country/Region (2025)
Figure 10. Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Acellular Pertussis Vaccine
Figure 12. Product Picture of Whole-cell Pertussis Vaccine
Figure 13. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type in 2026
Figure 14. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021-2026)
Figure 15. Maternal Pertussis Vaccine for Newborn Protection Consumed in Hospital
Figure 16. Global Maternal Pertussis Vaccine for Newborn Protection Market: Hospital (2021-2026) & (Dose)
Figure 17. Maternal Pertussis Vaccine for Newborn Protection Consumed in Centers for Disease Control and Prevention
Figure 18. Global Maternal Pertussis Vaccine for Newborn Protection Market: Centers for Disease Control and Prevention (2021-2026) & (Dose)
Figure 19. Maternal Pertussis Vaccine for Newborn Protection Consumed in Others
Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Market: Others (2021-2026) & (Dose)
Figure 21. Global Maternal Pertussis Vaccine for Newborn Protection Sale Market Share by Application (2025)
Figure 22. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application in 2026
Figure 23. Maternal Pertussis Vaccine for Newborn Protection Sales by Company in 2026 (Dose)
Figure 24. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Company in 2026
Figure 25. Maternal Pertussis Vaccine for Newborn Protection Revenue by Company in 2026 ($ millions)
Figure 26. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Company in 2026
Figure 27. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Maternal Pertussis Vaccine for Newborn Protection Sales 2021-2026 (Dose)
Figure 30. Americas Maternal Pertussis Vaccine for Newborn Protection Revenue 2021-2026 ($ millions)
Figure 31. APAC Maternal Pertussis Vaccine for Newborn Protection Sales 2021-2026 (Dose)
Figure 32. APAC Maternal Pertussis Vaccine for Newborn Protection Revenue 2021-2026 ($ millions)
Figure 33. Europe Maternal Pertussis Vaccine for Newborn Protection Sales 2021-2026 (Dose)
Figure 34. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales 2021-2026 (Dose)
Figure 36. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Revenue 2021-2026 ($ millions)
Figure 37. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2026
Figure 38. Americas Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Figure 40. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2026)
Figure 41. United States Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region in 2026
Figure 46. APAC Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Figure 48. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2026)
Figure 49. China Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2026
Figure 57. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Figure 59. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2026)
Figure 60. Germany Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Maternal Pertussis Vaccine for Newborn Protection in 2026
Figure 74. Manufacturing Process Analysis of Maternal Pertussis Vaccine for Newborn Protection
Figure 75. Industry Chain Structure of Maternal Pertussis Vaccine for Newborn Protection
Figure 76. Channels of Distribution
Figure 77. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Maternal Pertussis Vaccine for Newborn Protection
Figure 2. Maternal Pertussis Vaccine for Newborn Protection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate 2021-2032 (Dose)
Figure 7. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Maternal Pertussis Vaccine for Newborn Protection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country/Region (2025)
Figure 10. Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Acellular Pertussis Vaccine
Figure 12. Product Picture of Whole-cell Pertussis Vaccine
Figure 13. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type in 2026
Figure 14. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021-2026)
Figure 15. Maternal Pertussis Vaccine for Newborn Protection Consumed in Hospital
Figure 16. Global Maternal Pertussis Vaccine for Newborn Protection Market: Hospital (2021-2026) & (Dose)
Figure 17. Maternal Pertussis Vaccine for Newborn Protection Consumed in Centers for Disease Control and Prevention
Figure 18. Global Maternal Pertussis Vaccine for Newborn Protection Market: Centers for Disease Control and Prevention (2021-2026) & (Dose)
Figure 19. Maternal Pertussis Vaccine for Newborn Protection Consumed in Others
Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Market: Others (2021-2026) & (Dose)
Figure 21. Global Maternal Pertussis Vaccine for Newborn Protection Sale Market Share by Application (2025)
Figure 22. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application in 2026
Figure 23. Maternal Pertussis Vaccine for Newborn Protection Sales by Company in 2026 (Dose)
Figure 24. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Company in 2026
Figure 25. Maternal Pertussis Vaccine for Newborn Protection Revenue by Company in 2026 ($ millions)
Figure 26. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Company in 2026
Figure 27. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Maternal Pertussis Vaccine for Newborn Protection Sales 2021-2026 (Dose)
Figure 30. Americas Maternal Pertussis Vaccine for Newborn Protection Revenue 2021-2026 ($ millions)
Figure 31. APAC Maternal Pertussis Vaccine for Newborn Protection Sales 2021-2026 (Dose)
Figure 32. APAC Maternal Pertussis Vaccine for Newborn Protection Revenue 2021-2026 ($ millions)
Figure 33. Europe Maternal Pertussis Vaccine for Newborn Protection Sales 2021-2026 (Dose)
Figure 34. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales 2021-2026 (Dose)
Figure 36. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Revenue 2021-2026 ($ millions)
Figure 37. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2026
Figure 38. Americas Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Figure 40. Americas Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2026)
Figure 41. United States Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region in 2026
Figure 46. APAC Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Figure 48. APAC Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2026)
Figure 49. China Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country in 2026
Figure 57. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Figure 59. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2026)
Figure 60. Germany Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Maternal Pertussis Vaccine for Newborn Protection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Maternal Pertussis Vaccine for Newborn Protection in 2026
Figure 74. Manufacturing Process Analysis of Maternal Pertussis Vaccine for Newborn Protection
Figure 75. Industry Chain Structure of Maternal Pertussis Vaccine for Newborn Protection
Figure 76. Channels of Distribution
Figure 77. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share Forecast by Application (2027-2032)
